The FDA has appointed George Tidmarsh, a physician-scientist and seasoned biotech executive with experience at Horizon Pharma and La Jolla Pharma, as the director of its Center for Drug Evaluation and Research (CDER). Tidmarsh brings a blend of medical, scientific, and operational expertise to the role, aiming to guide drug development oversight with a comprehensive understanding of the industry. His appointment signals a continued FDA leadership focus on bridging regulatory and scientific perspectives.